Abstract:Transforming growth factor-beta (TGF beta) is crucial for liver fibrogenesis and the blunting of TGF beta signalling in hepatic stellate cells (HSCs) or hepatocytes can effectively inhibit liver fibrosis. microRNAs (miRNAs) have emerged as key regulators in modulating TGF beta signalling and liver fibrogenesis. However, the regulation of TGF beta receptor I (T beta RI) production by miRNA remains poorly understood. Here we demonstrate that the miR-101 family members act as suppressors of TGF beta signalling by targeting T beta RI and its transcriptional activator Kruppel-like factor 6 (KLF6) during liver fibrogenesis. Using a mouse model of carbon tetrachloride (CCl4)-induced liver fibrosis, we conducted a time-course experiment and observed significant down-regulation of miR-101 in the fibrotic liver as well as in the activated HSCs and injured hepatocytes in the process of liver fibrosis. Meanwhile, up-regulation of T beta RI/KLF6 was observed in the fibrotic liver. Subsequent investigations validated that T beta RI and KLF6 were direct targets of miR-101. Lentivirus-mediated ectopic expression of miR-101 in liver greatly reduced CCl4-induced liver fibrosis, whereas intravenous administration of antisense miR-101 oligonucleotides aggravated hepatic fibrogenesis. Mechanistic studies revealed that miR-101 inhibited profibrogenic TGF beta signalling by suppressing T beta RI expression in both HSCs and hepatocytes. Additionally, miR-101 promoted the reversal of activated HSCs to a quiescent state, as indicated by suppression of proliferation and migration, loss of activation markers and gain of quiescent HSC-specific markers. In hepatocytes, miR-101 attenuated profibrogenic TGF beta signalling and suppressed the consequent up-regulation of profibrogenic cytokines, as well as TGF beta-induced hepatocyte apoptosis and the inhibition of cell proliferation. The pleiotropic roles of miR-101 in hepatic fibrogenesis suggest that it could be a potential therapeutic target for liver fibrosis. Copyright (C) 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation

PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/-catenin signalling pathway

MicroRNA-101 Suppresses Liver Fibrosis by Downregulating PI3K/Akt/mTOR Signaling Pathway

MLKL deficiency attenuated hepatocyte oxidative DNA damage by activating mitophagy to suppress macrophage cGAS-STING signaling during liver ischemia and reperfusion injury

Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis

MLKL Promotes Hepatocarcinogenesis Through Inhibition of AMPK-mediated Autophagy

MLKL Attenuates Colon Inflammation and Colitis-Tumorigenesis Via Suppression of Inflammatory Responses

Deletion of Protein Kinase D3 Promotes Liver Fibrosis in Mice

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis

Delta-like 1 Serves as a New Target and Contributor to Liver Fibrosis Down-regulated by Mesenchymal Stem Cell Transplantation

Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

Unc-51 Like Autophagy Activating Kinase 1 Knockout Protects Against Carbon Tetrachloride-induced Liver Fibrosis: the Role of Autophagy

A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma

TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice

MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.

MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression

Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling

Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway.

Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis